The global implantable cardioverter defibrillator (ICD) devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of cardiovascular diseases and rising awareness about the benefits of ICDs. The single-chamber ICD segment accounted for the largest share in the global implantable cardioverter defibrillator (ICD) devices market in 2018, followed by dual-chamber ICDs and bradycardia applications. The single-chamber ICD segment is expected to continue its dominance throughout the forecast period due to its lower cost and ease of use. -The ICD market is expected to grow at a CAGR of 3.5% from 2017 to 2022. -The ICD market is driven by the increasing prevalence of cardiovascular diseases, rising awareness about the benefits of ICDs, and technological advancements in the field. -Increasing prevalence of cardiovascular diseases will drive the growth of this market as it increases the risk for sudden cardiac arrest and death. -Rising awareness about benefits of ICDs will also drive this market as it helps patients understand their condition and how an implantable cardioverter defibrillator can help them.
Industry Growth Insights published a new data on “Implantable Cardioverter Defibrillator (ICD) Devices Market”. The research report is titled “Implantable Cardioverter Defibrillator (ICD) Devices Market research by Types (Single-Chamber ICD, Dual-Chamber ICD), By Applications (Bradycardia, Tachycardia, Heart Failure, Others), By Players/Companies Medtronic, St. Jude Medical, Boston Scientific, Biotronik, LivaNova, Pacetronix, ...”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Cardioverter Defibrillator (ICD) Devices Market Research Report
By Type
Single-Chamber ICD, Dual-Chamber ICD
By Application
Bradycardia, Tachycardia, Heart Failure, Others
By Companies
Medtronic, St. Jude Medical, Boston Scientific, Biotronik, LivaNova, Pacetronix, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Cardioverter Defibrillator (ICD) Devices Market Report Segments:
The global Implantable Cardioverter Defibrillator (ICD) Devices market is segmented on the basis of:
Types
Single-Chamber ICD, Dual-Chamber ICD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bradycardia, Tachycardia, Heart Failure, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- St. Jude Medical
- Boston Scientific
- Biotronik
- LivaNova
- Pacetronix
- ...
Highlights of The Implantable Cardioverter Defibrillator (ICD) Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single-Chamber ICD
- Dual-Chamber ICD
- By Application:
- Bradycardia
- Tachycardia
- Heart Failure
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Cardioverter Defibrillator (ICD) Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An implantable cardioverter defibrillator (ICD) is a medical device that helps to prevent sudden cardiac death. ICDs are inserted into the heart and connected to electrical wires that send electrical shocks through the heart if it begins to beat too fast or too slow. This can help to correct the problem and keep your heart functioning properly.
Some of the major companies in the implantable cardioverter defibrillator (icd) devices market are Medtronic, St. Jude Medical, Boston Scientific, Biotronik, LivaNova, Pacetronix.
The implantable cardioverter defibrillator (icd) devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Implantable Cardioverter Defibrillator (ICD) Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Implantable Cardioverter Defibrillator (ICD) Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Implantable Cardioverter Defibrillator (ICD) Devices Market - Supply Chain
4.5. Global Implantable Cardioverter Defibrillator (ICD) Devices Market Forecast
4.5.1. Implantable Cardioverter Defibrillator (ICD) Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Implantable Cardioverter Defibrillator (ICD) Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Implantable Cardioverter Defibrillator (ICD) Devices Market Absolute $ Opportunity
5. Global Implantable Cardioverter Defibrillator (ICD) Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Type
5.3.1. Single-Chamber ICD
5.3.2. Dual-Chamber ICD
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Implantable Cardioverter Defibrillator (ICD) Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Application
6.3.1. Bradycardia
6.3.2. Tachycardia
6.3.3. Heart Failure
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Implantable Cardioverter Defibrillator (ICD) Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Implantable Cardioverter Defibrillator (ICD) Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Implantable Cardioverter Defibrillator (ICD) Devices Demand Share Forecast, 2019-2029
9. North America Implantable Cardioverter Defibrillator (ICD) Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Application
9.4.1. Bradycardia
9.4.2. Tachycardia
9.4.3. Heart Failure
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Type
9.7.1. Single-Chamber ICD
9.7.2. Dual-Chamber ICD
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Implantable Cardioverter Defibrillator (ICD) Devices Demand Share Forecast, 2019-2029
10. Latin America Implantable Cardioverter Defibrillator (ICD) Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Application
10.4.1. Bradycardia
10.4.2. Tachycardia
10.4.3. Heart Failure
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Type
10.7.1. Single-Chamber ICD
10.7.2. Dual-Chamber ICD
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Implantable Cardioverter Defibrillator (ICD) Devices Demand Share Forecast, 2019-2029
11. Europe Implantable Cardioverter Defibrillator (ICD) Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Application
11.4.1. Bradycardia
11.4.2. Tachycardia
11.4.3. Heart Failure
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Type
11.7.1. Single-Chamber ICD
11.7.2. Dual-Chamber ICD
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Implantable Cardioverter Defibrillator (ICD) Devices Demand Share, 2019-2029
12. Asia Pacific Implantable Cardioverter Defibrillator (ICD) Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Application
12.4.1. Bradycardia
12.4.2. Tachycardia
12.4.3. Heart Failure
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Type
12.7.1. Single-Chamber ICD
12.7.2. Dual-Chamber ICD
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Implantable Cardioverter Defibrillator (ICD) Devices Demand Share, 2019-2029
13. Middle East & Africa Implantable Cardioverter Defibrillator (ICD) Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Application
13.4.1. Bradycardia
13.4.2. Tachycardia
13.4.3. Heart Failure
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Implantable Cardioverter Defibrillator (ICD) Devices Market Size and Volume Forecast by Type
13.7.1. Single-Chamber ICD
13.7.2. Dual-Chamber ICD
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Implantable Cardioverter Defibrillator (ICD) Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Implantable Cardioverter Defibrillator (ICD) Devices Market: Market Share Analysis
14.2. Implantable Cardioverter Defibrillator (ICD) Devices Distributors and Customers
14.3. Implantable Cardioverter Defibrillator (ICD) Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. St. Jude Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biotronik
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. LivaNova
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pacetronix
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ...
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook